What do I talk about when I talk about measuring CNS orexin-A? Considerations of orexin-A measurements in clinical and preclinical setting

Sakurai, 1998, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell, 92, 573, 10.1016/S0092-8674(00)80949-6 de Lecea, 1998, The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc Natl Acad Sci U S A, 95, 322, 10.1073/pnas.95.1.322 Lin, 1999, The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene, Cell, 98, 365, 10.1016/S0092-8674(00)81965-0 Chemelli, 1999, Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation, Cell, 98, 437, 10.1016/S0092-8674(00)81973-X Nishino, 2000, Hypocretin (orexin) deficiency in human narcolepsy, Lancet, 355, 39, 10.1016/S0140-6736(99)05582-8 Hoofnagle, 2009, The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry, J Immunol Methods, 347, 3, 10.1016/j.jim.2009.06.003 Strathmann, 2011, Current and future applications of mass spectrometry to the clinical laboratory, Am J Clin Pathol, 136, 609, 10.1309/AJCPW0TA8OBBNGCK Ripley, 2001, Hypocretin levels in sporadic and familial cases of canine narcolepsy, Neurobiol Dis, 8, 525, 10.1006/nbdi.2001.0389 Kastin, 1999, Orexin A but not orexin B rapidly enters brain from blood by simple diffusion, J Pharmacol Exp Ther, 289, 219 Mignot, 2002, The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias, Arch Neurol, 59, 1553, 10.1001/archneur.59.10.1553 Mondal, 1999, Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models, Neurosci Lett, 273, 45, 10.1016/S0304-3940(99)00624-2 Arihara, 2000, Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma, Peptides, 21, 565, 10.1016/S0196-9781(00)00184-4 Mäkelä, 2018, Plasma orexin-A levels do not undergo circadian rhythm in young healthy male subjects, Front Endocrinol (Lausanne), 9, 710, 10.3389/fendo.2018.00710 Sakai, 2019, HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy, Sci Rep, 9, 477, 10.1038/s41598-018-36942-8 American Psychiatric Association, 2013 American Academy of Sleep Medicine, 2014 Nishino, 2005, Hypocretin measurements in the CSF, and blood and brain tissue. Basic and clinical applications, 73 Date, 2000, Distribution of orexin/hypocretin in the rat median eminence and pituitary, Brain Res Mol Brain Res, 76, 1, 10.1016/S0169-328X(99)00317-4 Date Y, Mondal MS, Matsukura S, Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett. 2000;288(2):87-90. doi: doi.org/10.1016/S0304-3940(00)01195-2. Kukkonen, 2012, Recent progress in orexin/hypocretin physiology and pharmacology, Biomol Concepts, 3, 447, 10.1515/bmc-2012-0013 Hirtz, 2016, From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid, Sci Rep, 6, 25162, 10.1038/srep25162 Bårdsen, 2019, Considerably lower levels of hypocretin-1 in cerebrospinal fluid is revealed by a novel mass spectrometry method compared with standard radioimmunoassay, Anal Chem, 91, 9323, 10.1021/acs.analchem.9b02710 Lindström, 2021, Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays, Clin Biochem, 90, 34, 10.1016/j.clinbiochem.2021.01.009 Nishino, 2001, Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy, Ann Neurol, 50, 381, 10.1002/ana.1130 Keating, 2017, Hypocretin measurement: shelf age of radioimmunoassay kit, but not freezer time, influences assay variability, Scand J Clin Lab Invest, 77, 390, 10.1080/00365513.2017.1325928 Schoneich, 2019, Thiyl radical reactions in the chemical degradation of pharmaceutical proteins, Molecules, 24, 10.3390/molecules24234357 Wang, 1999, Instability, stabilization, and formulation of liquid protein pharmaceuticals, Int J Pharm, 185, 129, 10.1016/S0378-5173(99)00152-0 Ono, 2018, Measurement of cerebrospinal fluid orexin-A (hypocretin-1) by enzyme-linked immunosorbent assay: A comparison with radioimmunoassay, Psychiatry Clin Neurosci, 72, 849, 10.1111/pcn.12780 Zhang, 2007, The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats, Neuroscience, 148, 34, 10.1016/j.neuroscience.2007.05.029 Weiss, 2014, Catch and measure-mass spectrometry-based immunoassays in biomarker research, Biochim Biophys Acta, 1844, 927, 10.1016/j.bbapap.2013.09.010 Fung, 2020, Emerging role of clinical mass spectrometry in pathology, J Clin Pathol, 73, 61, 10.1136/jclinpath-2019-206269 Tabuchi, 2014, Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function, J Neurosci, 34, 6495, 10.1523/JNEUROSCI.0073-14.2014